# Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer

> **NCT00957086** · PHASE3 · UNKNOWN · sponsor: **National Cancer Centre, Singapore** · enrollment: 710 (estimated)

## Conditions studied

- Carcinoma, Squamous Cell of Head and Neck

## Interventions

- **DRUG:** Nimotuzumab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00957086
- **Lead sponsor:** National Cancer Centre, Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-08-13
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-01-01
- **Target enrollment:** 710 (ESTIMATED)
- **Last updated:** 2024-01-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00957086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00957086, "Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00957086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*